![]() |
| Photo Credit: National Cancer Institute |
Patients who were referred to urgent suspected cancer pathways, but were found not to have cancer at that time, have a higher risk of subsequent cancer in the 1-5 years following the ‘all clear’ than those who haven’t been through the referral pathways.
The study, published today in Lancet Oncology, is the first to examine the risk of cancer in patients in England who entered the urgent suspected cancer pathway but were found not to have cancer at that time. These patients were found to have a higher-than-expected risk of subsequent cancer in the 1-5 years after the initial ‘all clear’.
In England, the urgent suspected cancer referral pathway is the most common route to diagnosis. Of the 3 million patients who are referred for urgent cancer assessments in England each year, 7% are found to have cancer. This leaves a large group of patients who go through these pathways but do not have cancer at the time – a group that is currently understudied and who may be in need of support.

.jpg)


.jpg)


.jpg)

